Clinical Validation of the Intermediate-risk Non–muscle-invasive Bladder Cancer Scoring System and Substratification Model Proposed by the International Bladder Cancer Group: A Multicenter Young Academic Urologists Urothelial Working Group CollaborationFrancesco Soria, Paolo Gontero, Renate Pichler et al.|European Urology Oncology|2024Cited by 32
The Impact of Primary Versus Secondary Muscle-invasive Bladder Cancer at Diagnosis on the Response to Neoadjuvant ChemotherapyDavid D‘Andrea, Marco Moschini, Shahrokh F. Shariat et al.|European Urology Open Science|2022Cited by 14
Prognosis of patients with T1 low-grade urothelial bladder cancer treated with bacillus Calmette-Guérin immunotherapyRadosław Piszczek, Tomasz Szydełko, Wojciech Krajewski et al.|Minerva Urology and Nephrology|2023Cited by 9